Exomas
Rosario
About Exomas
Exomas develops disruptive solutions based on exosomes derived from neural stem cells for the preventive or regenerative treatment of nervous tissue affected by neurodegenerative diseases. These exosomes have the ability to induce the proliferation of neural stem cells and their differentiation into functional neurons, thus exerting a neuroregenerative effect on the affected tissue.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $281.1K
- Funding stage: Seed
- Last round: Grant (Jul 2025)
- Website: exomas.co
- Phone: 3415069897
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/exomas-89281 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.